Insider filing · ZVRA
Rahsaan Thompson
Chief Legal & Compliance
profile →
Zevra Therapeutics, Inc.
ZVRA · Healthcare · 9 filings in 24 months
ticker →
Rahsaan Thompson sold $438K of Zevra Therapeutics (ZVRA)
Executed Jun 22, disclosed Jun 23, 1 day later.
Value, as filed
$438K
34,557 sh × $12.68
Executed
Jun 22
the trade date, as filed
Disclosed
Jun 23
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RTRahsaan Thompson (Chief Legal & Compliance) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Zevra Therapeutics, Inc. (ZVRA). The largest single filing was $475K of ZVRA (42,666 sh × $11.13, as filed), executed Aug 14.
The name
ZVRAHealthcare · Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United St…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Rahsaan Thompson in ZVRA
ZVRASALE
Zevra Therapeutics, Inc.
$475K42,666 sh × $11.13
Exec Aug 14
Filed Aug 17 · 4:32 PM ET ZVRASALE Zevra Therapeutics, Inc. $221K
24,000 sh × $9.21
Exec Jun 26 2025
Filed Jun 30 2025 · 5:30 PM ET